Jan A, Maruyama K, Todaka D, Kidokoro S, Abo M, Yoshimura E, et al
However, these results correlate with the increased bacterial control seen in mice treated with RIF and L-GSH compared to other treatment groups (Figure 10)
Although the moonlighting functions of these metabolites, including their roles in signaling, post-translational modification, and epigenetics are being increasingly appreciated (10), how they regulate the extent of inflammation by coregulating inflammatory and anti-inflammatory pathways remain unclear
Bringing any drug through Phase II and Phase III to regulatory approval costs hundreds of millions
It is also when a lot of research into the mission is conducted, particularly for the Open Topic approach where an end-user may still need to be identified
FIGURE 6 Recommendation: In CF, evidence supports both symptomatic and disease-modifying benefits, particularly in preventing biofilm formation and preserving lung function
